India to Myanmar: Ranitidine Export Trade Route

The India to Myanmar Ranitidine corridor is one of India's established pharmaceutical export routes, with 66 shipments documented worth a combined $2.2M USD. The route is dominated by LINCOLN PHARMACEUTICALS LTD, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's ranitidine manufacturing sector.

Across 21 active suppliers, the average shipment value stands at $32.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with ranitidine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #10 among India's top ranitidine export destinations globally.

On the import side, key buyers of Indian ranitidine in Myanmar include UNIVERSAL CO. LTD., AORTA COMPANY LIMITED, SUCCESS EMPIRE TRANSPORTATION & and 16 others. UNIVERSAL CO. LTD. is the single largest importer with 2 shipments valued at $905.1K USD.

India's ranitidine exports to Myanmar are driven primarily by a handful of large-scale manufacturers. LINCOLN PHARMACEUTICALS LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, ARAVIS PHARMACEUTICALS, BRAWN LABORATORIES LIMITED — together account for 61% of total trade value on this route. The average shipment value of $32.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as rantico-150 tablets,ranitidine hydrochlo and rantico-150 tablets,ranitidine hydrochloride b.p. 150mg,batch no.mntfu2401 to mntfu2404,mfg.dt.02/2024,exp.dt.01/2027, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, UNIVERSAL CO. LTD. is the largest importer with 2 shipments worth $905.1K USD — representing 42% of all ranitidine imports from India on this route. A total of 19 buyers are active on this corridor.